Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > UK raises alarm over new COVID variant which could beat vacc

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Nov 26, 2021 6:10am

108 Views

Post# 34167739

RE:RE:UK raises alarm over new COVID variant which could beat vacc

I wonder how many people in Canada realize that the UK and the US no longer have a mask mandate for the general public?

It seems that the up north are prisoners to their government.